Published in
Elsevier, American Journal of Kidney Diseases, 2(79), p. 244-256.e1, 2022
DOI: 10.1053/j.ajkd.2021.05.005
Links
Tools
Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial
Journal article published in 2021 by
Hiddo J. L. Heerspink 
,
Megumi Oshima,
Hong Zhang,
Jingwei Li,
Rajiv Agarwal,
George Capuano,
David M. Charytan ,
Jagriti Craig,
Dick de Zeeuw,
Gian Luca Di Tanna,
Adeera Levin,
Bruce Neal,
Vlado Perkovic,
David C. Wheeler,
Yshai Yavin
and other authors.
,
Megumi Oshima,
Hong Zhang,
Jingwei Li,
Rajiv Agarwal,
George Capuano,
David M. Charytan ,
Jagriti Craig,
Dick de Zeeuw,
Gian Luca Di Tanna,
Adeera Levin,
Bruce Neal,
Vlado Perkovic,
David C. Wheeler,
Yshai Yavin
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 